However, the PFS difference did not reach statistical significance (P=0.088), which that can be explained by the small number of patients included in our trial.
← all excerpts
Cytoreductive surgery in patients with recurrent or metastatic gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of two Russian cancer centers.
1
0.0880
0.0880